Mayne Pharma Group Ltd.ASX: MYX

Supreme Court Decision in Cosette Proceedings

· Issued by Mayne Pharma Group Ltd. via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Mayne Pharma Group Ltd. announced the Supreme Court's decision regarding the Cosette proceedings, which dismissed Cosette's appeal on all grounds and awarded costs to Mayne Pharma. The Court affirmed that no material adverse change occurred and that Mayne Pharma did not engage in misleading conduct regarding its financial performance. Mayne Pharma's Board Chair expressed satisfaction with the ruling and emphasized the company's commitment to maximizing shareholder value. Cosette has until a specified date to consider further appeal options to the High Court.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/supreme-court-decision-in-cosette-proceedings

Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call

Release

ASX Announcement SUPREME COURT DECISION IN COSETTE PROCEEDINGS 14 October 2026, Adelaide, Australia: Mayne Pharma Group Limited (ASX: MYX) (Mayne Pharma) refers to its announcement on 15 January 2026 relating to the notice of appeal filed by Cosette with the Supreme Court of New South ...

Mayne Pharma Group Ltd. on 6ix

Story so far

Earlier from Mayne Pharma

Later from Mayne Pharma

All Mayne Pharma news releases